XML 26 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-based compensation
9 Months Ended
Oct. 31, 2017
Stock-based compensation [Abstract]  
Stock-based compensation [Text Block]
Stock-based compensation. The Company has stock-based compensation awards that can be granted to eligible employees, officers or directors.
 
Three Months Ended October 31,
Nine Months Ended October 31,
 
2017

2016

2017

2016

Stock-based compensation expense

$21


$55


$80


$216

Restricted stock-based compensation expense

$294


$151


$938


$819



Stock Options. The fair value of the outstanding option awards was estimated on the grant dates using the Black-Scholes option pricing model.
 
Nine Months Ended October 31,
Fair value assumptions
2017
2016
Expected volatility
43.2%
43.2%
Risk free interest rate
1.2%
1.2%
Dividend yield
0
0
Expected life
5.0
5.0


Option activity
Options
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term
Aggregate Intrinsic Value
Outstanding at January 31, 2017
524


$11.55

4.5

$534

Exercised
(30
)
6.77

 
37

Expired or forfeited
(125
)
18.75

 
 
Outstanding end of period
369

9.50

4.3
338

 
 
 
 
 
Exercisable end of period
335


$9.62

3.9

$303



Unvested option activity
Options
Weighted Average Grant Date Fair Value
Aggregate Intrinsic Value
Outstanding at January 31, 2017
74


$9.31


$69

Vested
(32
)
 
 
Expired or forfeited
(8
)
11.49

 
Outstanding end of period
34


$8.32


$35



As of October 31, 2017, there was $0.1 million of total unrecognized compensation expense related to unvested stock options. The expense is expected to be recognized over a period of 1.8 years.

Restricted stock. The following table summarizes restricted stock activity for the year:
Restricted stock activity
Restricted Shares
Weighted Average Grant Price Per Share
Aggregate Intrinsic Value
Outstanding at January 31, 2017
290


$8.75


$2,540

Granted
172

8.02

 
Issued
(55
)
 
 
Forfeited
(39
)
7.86

 
Outstanding end of period
368


$8.35


$2,955



As of October 31, 2017, there was $1.6 million of unrecognized compensation expense related to unvested restricted stock granted under the plans. The cost is expected to be recognized over the weighted-average period of 2.2 years.